Literature DB >> 23725547

A comparison of three-dimensional culture systems to evaluate in vitro chondrogenesis of equine bone marrow-derived mesenchymal stem cells.

Ashlee E Watts1, Jeremy C Ackerman-Yost, Alan J Nixon.   

Abstract

OBJECTIVE: To compare in vitro three-dimensional (3D) culture systems that model chondrogenesis of bone marrow-derived mesenchymal stem cells (MSCs).
METHODS: MSCs from five horses 2-3 years of age were consolidated in fibrin 0.3% alginate, 1.2% alginate, 2.5×10(5) cell pellets, 5×10(5) cell pellets, and 2% agarose, and maintained in chondrogenic medium with supplemental TGF-β1 for 4 weeks. Pellets and media were tested at days 1, 14, and 28 for gene expression of markers of chondrogenic maturation and hypertrophy (ACAN, COL2B, COL10, SOX9, 18S), and evaluated by histology (hematoxylin and eosin, Toluidine Blue) and immunohistochemistry (collagen type II and X).
RESULTS: alginate, fibrin alginate (FA), and both pellet culture systems resulted in chondrogenic transformation. Adequate RNA was not obtained from agarose cultures at any time point. There was increased COL2B, ACAN, and SOX9 expression on day 14 from both pellet culture systems. On day 28, increased expression of COL2B was maintained in 5×10(5) cell pellets and there was no difference in ACAN and SOX9 between FA and both pellet cultures. COL10 expression was significantly lower in FA cultures on day 28. Collagen type II was abundantly formed in all culture systems except alginate and collagen type X was least in FA hydrogels.
CONCLUSION: equine MSCs respond to 3D culture in FA blended hydrogel and both pellet culture systems with chondrogenic induction. For prevention of terminal differentiation and hypertrophy, FA culture may be superior to pellet culture systems.

Entities:  

Mesh:

Year:  2013        PMID: 23725547      PMCID: PMC3761431          DOI: 10.1089/ten.TEA.2012.0479

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  37 in total

Review 1.  Articular cartilage repair with autologous bone marrow mesenchymal cells.

Authors:  Tomiya Matsumoto; Takahiro Okabe; Tesshu Ikawa; Takahiro Iida; Hiroyuki Yasuda; Hiroaki Nakamura; Shigeyuki Wakitani
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 2.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

3.  Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model.

Authors:  Lisa A Fortier; Hollis G Potter; Ellen J Rickey; Lauren V Schnabel; Li Foong Foo; Leroy R Chong; Tracy Stokol; Jon Cheetham; Alan J Nixon
Journal:  J Bone Joint Surg Am       Date:  2010-08-18       Impact factor: 5.284

4.  Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells.

Authors:  Y Kasashima; T Ueno; A Tomita; A E Goodship; R K W Smith
Journal:  Equine Vet J       Date:  2010-09-23       Impact factor: 2.888

5.  Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects.

Authors:  C Wayne McIlwraith; David D Frisbie; William G Rodkey; John D Kisiday; Natasha M Werpy; Christopher E Kawcak; J Richard Steadman
Journal:  Arthroscopy       Date:  2011-08-20       Impact factor: 4.772

6.  Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model.

Authors:  Markus M Wilke; Daryl V Nydam; Alan J Nixon
Journal:  J Orthop Res       Date:  2007-07       Impact factor: 3.494

Review 7.  Donor site morbidity after articular cartilage repair procedures: a review.

Authors:  Giovanni A Matricali; Greta Ph E Dereymaeker; Frank P Luyten
Journal:  Acta Orthop Belg       Date:  2010-10       Impact factor: 0.500

8.  Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months.

Authors:  Shigeyuki Wakitani; Takahiro Okabe; Shuji Horibe; Tomoki Mitsuoka; Masanobu Saito; Tsuyoshi Koyama; Masashi Nawata; Keiji Tensho; Hiroyuki Kato; Kota Uematsu; Ryosuke Kuroda; Masahiro Kurosaka; Shinichi Yoshiya; Koji Hattori; Hajime Ohgushi
Journal:  J Tissue Eng Regen Med       Date:  2011-02       Impact factor: 3.963

9.  The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells.

Authors:  Saey T B Ho; Simon M Cool; James H Hui; Dietmar W Hutmacher
Journal:  Biomaterials       Date:  2009-10-03       Impact factor: 12.479

Review 10.  The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?

Authors:  Per Qvist; Anne-Christine Bay-Jensen; Claus Christiansen; Erik B Dam; Philippe Pastoureau; Morten A Karsdal
Journal:  Pharmacol Res       Date:  2008-06-08       Impact factor: 7.658

View more
  20 in total

Review 1.  Transcriptional networks controlling stromal cell differentiation.

Authors:  Alexander Rauch; Susanne Mandrup
Journal:  Nat Rev Mol Cell Biol       Date:  2021-04-09       Impact factor: 94.444

2.  Gelatin microspheres releasing transforming growth factor drive in vitro chondrogenesis of human periosteum derived cells in micromass culture.

Authors:  Abhijith K Kudva; Anna D Dikina; Frank P Luyten; Eben Alsberg; Jennifer Patterson
Journal:  Acta Biomater       Date:  2019-03-21       Impact factor: 8.947

Review 3.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

Review 4.  The Use of Bone Marrow Concentrate in the Treatment of Full-Thickness Chondral Defects.

Authors:  John M Apostolakos; Lionel Lazaro; Riley J Williams
Journal:  HSS J       Date:  2018-11-26

Review 5.  Growing Pains: The Need for Engineered Platforms to Study Growth Plate Biology.

Authors:  Aleczandria S Tiffany; Brendan A C Harley
Journal:  Adv Healthc Mater       Date:  2022-08-15       Impact factor: 11.092

6.  A Dynamic Hanging-Drop System for Mesenchymal Stem Cell Culture.

Authors:  Shu-Wei Huang; Shian-Chiuan Tzeng; Jem-Kun Chen; Jui-Sheng Sun; Feng-Huei Lin
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

7.  Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and cord blood mesenchymal stromal/stem cells for cartilage regeneration.

Authors:  Rodolphe Rakic; Bastien Bourdon; Magali Demoor; Stéphane Maddens; Nathalie Saulnier; Philippe Galéra
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

8.  Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.

Authors:  Lauren V Schnabel; Lynn M Pezzanite; Douglas F Antczak; M Julia Bevilaqua Felippe; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2014-01-24       Impact factor: 6.832

9.  Improving cartilage phenotype from differentiated pericytes in tunable peptide hydrogels.

Authors:  Enateri V Alakpa; Vineetha Jayawarna; Karl E V Burgess; Christopher C West; Bruno Péault; Rein V Ulijn; Matthew J Dalby
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

Review 10.  Combating Osteoarthritis through Stem Cell Therapies by Rejuvenating Cartilage: A Review.

Authors:  Navneet Kumar Dubey; Viraj Krishna Mishra; Rajni Dubey; Shabbir Syed-Abdul; Joseph R Wang; Peter D Wang; Win-Ping Deng
Journal:  Stem Cells Int       Date:  2018-03-22       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.